MLchartDataset catalogue

Multi-kinase inhibitor T-1301

Term · Oncology and biomedicine · MLC-T-ONC-015355

An orally bioavailable small molecule inhibitor of multiple as of yet undisclosed kinases, with potential antineoplastic activity. Upon oral administration, multi-kinase inhibitor T-1301 inhibits the activity of multiple as of yet undisclosed kinases. This may result in antitumor activity in tumor cells in which these kinases are upregulated or dysregulated.

Table 1. Record
IdentifierMLC-T-ONC-015355
FieldOncology and biomedicine
Synonymsmultiple kinase inhibitor T-1301
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015355",
  "term": "Multi-kinase inhibitor T-1301",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable small molecule inhibitor of multiple as of yet undisclosed kinases, with potential antineoplastic activity. Upon oral administration, multi-kinase inhibitor T-1301 inhibits the activity of multiple as of yet undisclosed kinases. This may result in antitumor activity in tumor cells in which these kinases are upregulated or dysregulated.",
  "synonyms": [
    "multiple kinase inhibitor T-1301"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/multi-kinase-inhibitor-t-1301/"
}

Record 11,414 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.